Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis
NCT ID: NCT02404636
Last Updated: 2017-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2012-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Alcohol use
2. Dietary intake
3. Drug use (legal and illegal)
in the weeks preceding onset of acute alcoholic hepatitis. After interview patients are followed up for 12 months with regard to response to therapy and survival.
The study is intended to explore potential precipitants of alcoholic hepatitis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addiction Intervention in Liver Transplantation Candidates
NCT05322226
Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit
NCT05777200
Effective Treatment of Hepatitis C in Substance Users
NCT00633243
Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
NCT00571961
Evaluating a Culinary Curriculum Program for Residents of Medication Assisted Therapy (MAT) Recovery Houses
NCT07251205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alcoholic hepatitis
Individuals admitted to hospital with acute alcoholic hepatitis, defined as acute onset of jaundice in the context of recent hazardous alcohol use and the absence of other liver disease
Interview
Brief structured interview
Hazardous alcohol use
Individuals admitted to hospital for any cause who drink hazardous quantities of alcohol but without evidence of alcoholic hepatitis or advanced liver disease
Interview
Brief structured interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview
Brief structured interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged over 18 years
* able to give informed consent
Exclusion Criteria
* episode of alcoholic hepatitis in 6 months before admission
* severe hepatic encephalopathy
* delirium
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Parker
Clinical Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth Hospital Birmingham
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RRK4357
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.